PubRank

Joseph A Kovacs

Author PubWeight™ 93.66‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis 2008 4.86
2 ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathog 2007 4.82
3 Rapid antibody quantification and generation of whole proteome antibody response profiles using LIPS (luciferase immunoprecipitation systems). Biochem Biophys Res Commun 2006 2.56
4 Outbreaks of Pneumocystis pneumonia in 2 renal transplant centers linked to a single strain of Pneumocystis: implications for transmission and virulence. Clin Infect Dis 2012 2.51
5 Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood 2008 2.27
6 In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients. J Clin Invest 2005 1.96
7 IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood 2004 1.82
8 High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 2002 1.74
9 Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. J Clin Microbiol 2002 1.56
10 Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection. Clin Vaccine Immunol 2009 1.45
11 Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion. J Virol 2006 1.25
12 Quantitation of anti-Pneumocystis jiroveci antibodies in healthy persons and immunocompromised patients. J Infect Dis 2003 1.24
13 Metabolic and skeletal complications of HIV infection: the price of success. JAMA 2006 1.24
14 A Benchmark Study on Error Assessment and Quality Control of CCS Reads Derived from the PacBio RS. J Data Mining Genomics Proteomics 2013 1.23
15 Quantitative real-time polymerase chain-reaction assay allows characterization of pneumocystis infection in immunocompetent mice. J Infect Dis 2004 1.19
16 CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors. J Virol 2011 1.19
17 Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells. Blood 2002 1.18
18 A prospective, blinded study of quantitative touch-down polymerase chain reaction using oral-wash samples for diagnosis of Pneumocystis pneumonia in HIV-infected patients. J Infect Dis 2004 1.15
19 High sensitivity and specificity of acid-fast microscopy for diagnosis of pulmonary tuberculosis in an African population with a high prevalence of human immunodeficiency virus. J Clin Microbiol 2009 1.12
20 Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. J Infect Dis 2010 1.12
21 Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004 1.12
22 Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection. Proc Natl Acad Sci U S A 2002 1.12
23 Comprehensive analysis of unique cases with extraordinary control over HIV replication. Blood 2012 1.12
24 The incidence and natural history of osteonecrosis in HIV-infected adults. Clin Infect Dis 2007 1.11
25 Lopinavir-ritonavir: effects on endothelial cell function in healthy subjects. J Infect Dis 2006 1.09
26 Development of a rapid real-time PCR assay for quantitation of Pneumocystis carinii f. sp. carinii. J Clin Microbiol 2002 1.07
27 Induction and maintenance therapy with intermittent interleukin-2 in HIV-1 infection. Blood 2004 1.06
28 LIPS arrays for simultaneous detection of antibodies against partial and whole proteomes of HCV, HIV and EBV. Mol Biosyst 2011 1.04
29 Variation in the major surface glycoprotein genes in Pneumocystis jirovecii. J Infect Dis 2008 1.03
30 CD4+ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activation. J Infect Dis 2007 1.02
31 Proteome-wide anti-hepatitis C virus (HCV) and anti-HIV antibody profiling for predicting and monitoring the response to HCV therapy in HIV-coinfected patients. J Infect Dis 2010 1.01
32 Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice. J Leukoc Biol 2008 1.01
33 Analysis of variation in tandem repeats in the intron of the major surface glycoprotein expression site of the human form of Pneumocystis carinii. J Infect Dis 2002 1.00
34 Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes. Blood 2011 1.00
35 CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients. J Infect Dis 2008 0.99
36 Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. J Infect Dis 2002 0.99
37 Nucleic acid amplification tests for diagnosis of smear-negative TB in a high HIV-prevalence setting: a prospective cohort study. PLoS One 2011 0.98
38 Sequencing and characterization of the complete mitochondrial genomes of three Pneumocystis species provide new insights into divergence between human and rodent Pneumocystis. FASEB J 2013 0.97
39 HIV antibody characterization as a method to quantify reservoir size during curative interventions. J Infect Dis 2013 0.97
40 Restriction fragment length polymorphism typing demonstrates substantial diversity among Pneumocystis jirovecii isolates. J Infect Dis 2009 0.94
41 A single-copy gene encodes Kex1, a serine endoprotease of Pneumocystis jiroveci. Infect Immun 2003 0.93
42 Characterization of variants of the gene encoding the p55 antigen in Pneumocystis from rats and mice. J Med Microbiol 2003 0.92
43 HIV infection and antiretroviral therapy have divergent effects on mitochondria in adipose tissue. J Infect Dis 2012 0.92
44 Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels. AIDS 2009 0.91
45 Polymerase chain reaction of secA1 on sputum or oral wash samples for the diagnosis of pulmonary tuberculosis. Clin Infect Dis 2009 0.91
46 Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants. J Clin Pharmacol 2011 0.91
47 Pneumocystis encodes a functional S-adenosylmethionine synthetase gene. Eukaryot Cell 2007 0.90
48 Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjects. Pharmacotherapy 2010 0.90
49 Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments. J Infect Dis 2011 0.90
50 Elevations in D-dimer and C-reactive protein are associated with the development of osteonecrosis of the hip in HIV-infected adults. AIDS 2013 0.90
51 Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretroviral regimen. AIDS 2003 0.89
52 Discordant antibody and cellular responses to Pneumocystis major surface glycoprotein variants in mice. BMC Immunol 2012 0.88
53 Increases in CD4+ T lymphocytes occur without increases in thymic size in HIV-infected subjects receiving interleukin-2 therapy. J Acquir Immune Defic Syndr 2003 0.87
54 Inferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial. AIDS 2009 0.86
55 Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase. Antimicrob Agents Chemother 2002 0.85
56 Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand. Blood 2011 0.84
57 Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii. Transplantation 2013 0.83
58 Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals. AIDS 2012 0.82
59 HIV Infection, hepatitis C infection, and HAART: hard clinical choices. JAMA 2004 0.82
60 Characterization of the meiosis-specific recombinase Dmc1 of pneumocystis. J Infect Dis 2010 0.82
61 HCV in peripheral blood mononuclear cells are predominantly carried on the surface of cells in HIV/HCV co-infected individuals. J Med Virol 2010 0.82
62 The effect of intermittent IL-2 therapy on CD4 T cells in the gut in HIV-1-infected patients. J Acquir Immune Defic Syndr 2011 0.81
63 Fatigue-related gene networks identified in CD(14)+ cells isolated from HIV-infected patients: part I: research findings. Biol Res Nurs 2013 0.81
64 Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavir. J Acquir Immune Defic Syndr 2009 0.80
65 Transient elastography for the detection of hepatic fibrosis in HIV-monoinfected adults with elevated aminotransferases on antiretroviral therapy. AIDS 2015 0.80
66 Characterization of thioredoxin reductase genes (trr1) from Pneumocystis carinii and Pneumocystis jiroveci. Gene 2003 0.80
67 Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals. J Acquir Immune Defic Syndr 2008 0.80
68 Influence of low-dose ritonavir with and without darunavir on the pharmacokinetics and pharmacodynamics of inhaled beclomethasone. J Acquir Immune Defic Syndr 2013 0.80
69 Identification and characterization of rad51 of Pneumocystis. Gene 2006 0.79
70 Surrogate markers of immune function in human immunodeficiency virus-infected patients: what are they surrogates for? J Infect Dis 2003 0.78
71 Fatigue-related gene networks identified in CD14+ cells isolated from HIV-infected patients: part II: statistical analysis. Biol Res Nurs 2011 0.78
72 Altered antibody profiles against common infectious agents in chronic disease. PLoS One 2013 0.78
73 Galleria mellonella are resistant to Pneumocystis murina infection. Mycopathologia 2010 0.78
74 The Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma. AIDS Res Treat 2012 0.77
75 Plasma pharmacokinetics of sulfadiazine administered twice daily versus four times daily are similar in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2004 0.77
76 A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus. J Infect Dis 2003 0.76
77 Influence of Panax ginseng on the steady state pharmacokinetic profile of lopinavir-ritonavir in healthy volunteers. Pharmacotherapy 2014 0.76
78 Quantitative determinations of anti-Kaposi sarcoma-associated herpesvirus antibody levels in men who have sex with men. Diagn Microbiol Infect Dis 2013 0.75
79 Expression of Pneumocystis jirovecii major surface glycoprotein in Saccharomyces cerevisiae. J Infect Dis 2013 0.75
80 Characterization of pneumocystis major surface glycoprotein gene (msg) promoter activity in Saccharomyces cerevisiae. Eukaryot Cell 2013 0.75
81 Reply to Hauser et Al. Clin Infect Dis 2012 0.75
82 T-cell Activation and E-selectin Are Associated With Coronary Plaque in HIV-infected Young Adults. Pediatr Infect Dis J 2017 0.75
83 HIV-infected immunologic non-responders: can we provide a helping hand? Enferm Infecc Microbiol Clin 2008 0.75
84 The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsiveness. J Interferon Cytokine Res 2008 0.75
85 Does atovaquone provide effective prophylaxis for Pneumocystis pneumonia in children with leukemia? Nat Clin Pract Oncol 2007 0.75
86 Diagnosis of avascular necrosis of the hip in asymptomatic HIV-infected patients: Clinical correlation of physical examination with magnetic resonance imaging. J Back Musculoskelet Rehabil 2002 0.75
87 Inability of Pneumocystis organisms to incorporate bromodeoxyuridine suggests the absence of a salvage pathway for thymidine. Microbiology 2004 0.75